FILTER
FILTERED INTERVIEW RESULTS
Dr. Sharvil Patel
MANAGING DIRECTOR, ZYDUS CADILA
Zydus Cadila ranks fourth in the Indian pharmaceutical industry, with a strong global presence in the U.S., Europe, Latin America and South Africa, alongside 25 other emerging markets worldwide.
Dr. Kunal Saxena
MANAGING DIRECTOR, RUSAN PHARMA
Rusan Pharma is a fully integrated pharmaceutical company specializing in the treatment of addiction and pain management.
Serkan Barış
COUNTRY PRESIDENT, ASTRAZENECA
AstraZeneca Turkey provides an overview of its Turkish operations and opinions on the market.
Prof. Dr. Tanıl Kocagöz
HEAD OF DEPARTMENTS OF MEDICAL MICROBIOLOGY AND BIOTECHNOLOGY, ACIBADEM UNIVERSITY RESEARCH LABORATORY
Acibadem University is a private university founded in 2007, belonging to the Acibadem Healthcare Group. Professor Dr Kocagöz is a microbiology and infectious disease specialist.
Șirin Deha
FOUNDER & GM ERA PHARMA SOLUTIONS
ERA Pharma Solutions is a contract research organization (CRO) established in 2010 to provide drug discovery, development and lifecycle management services for the pharmaceutical industry.
James Sapirstein
PRESIDENT AND CEO, AZURRX BIOPHARMA
AzurRx BioPharma is a development stage biopharmaceutical company focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions.
Neha Ramani
PARTNER, LEXORBIS
Lex Orbis provides IP and legal services to the life science industry in India and beyond and comments on the exciting evolution of technology and research in India.
Dr. Trevor P. Castor
PRESIDENT & CEO, APHIOS
Aphios’ vision is to develop biotechnology products for improving health and treating chronic diseases in an environmentally sustainable manner.
Jay Shukla
PRESIDENT AND CEO, NIVAGEN PHARMACEUTICALS
Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and OTC products for the North American market.
Doug Giordano
SENIOR VP OF BUSINESS DEVELOPMENT, PFIZER
Pfizer outlines its plans to build its pipeline through partnerships as the company increasingly focuses on new science.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2024 - Digital Interactive
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
